Dublin, Aug. 24, 2023 (GLOBE NEWSWIRE) -- The "Women's Health Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
The global women's health market is poised to expand from $39.43 billion in 2022 to $41.4 billion in 2023, at a Compound Annual Growth Rate (CAGR) of 5%. By 2027, the market is expected to reach $49.86 billion, with a CAGR of 4.8%. This growth is driven by the rising prevalence of women-centric diseases and ongoing developments in the field.
Rising Prevalence of Women-Centric Diseases
Increasing occurrences of women-centric diseases such as anemia, osteoporosis, breast cancer, and menopause are key drivers of the women's health market. Risk factors like family history, age, obesity, and others contribute to the prevalence of these diseases. The World Health Organization (WHO) estimates that breast cancer diagnoses reached 2.3 million in 2020, with 685,000 fatalities globally. This rising prevalence emphasizes the need for women's health products and services to address these conditions.
Innovations in Women's Health
Innovations play a significant role in the women's health market. Companies are developing new products to enhance their market presence. For example, FemTec Health, a US-based startup, introduced BiomeAI in November 2021 - a data analytics platform that leverages genetic, consumer, microbiome, and biometric data for personalized care using deep machine learning and AI.
Market Movements
In May 2021, Partners Group, a Swiss private equity firm, acquired Axia Women's Health, strengthening its North American healthcare portfolio. Axia Women's Health, a US-based women's healthcare services firm, became part of this growing sector.
Regional Dynamics
North America led the women's health market in 2022, while Asia-Pacific is expected to be the fastest-growing region. The report covers Asia-Pacific, Western and Eastern Europe, North America, South America, and the Middle East and Africa.
Key Players
Prominent players in the women's health market include AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Amgen Inc., Novartis AG, AstraZeneca plc, and many more. These companies contribute to the market's growth through innovations, strategic acquisitions, and product offerings.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023-2027 |
| Estimated Market Value (USD) in 2023 | $41.4 Billion |
| Forecasted Market Value (USD) by 2027 | $49.86 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
Key Topics Covered
1. Executive Summary
2. Women's Health Market Characteristics
3. Women's Health Market Trends and Strategies
4. Women's Health Market Macro Economic Scenario
5. Women's Health Market Size and Growth
6. Women's Health Market Segmentation
7. Women's Health Market Regional and Country Analysis
8. Asia-Pacific Women's Health Market
9. China Women's Health Market
10. India Women's Health Market
11. Japan Women's Health Market
12. Australia Women's Health Market
13. Indonesia Women's Health Market
14. South Korea Women's Health Market
15. Western Europe Women's Health Market
16. UK Women's Health Market
17. Germany Women's Health Market
18. France Women's Health Market
19. Eastern Europe Women's Health Market
20. Russia Women's Health Market
21. North America Women's Health Market
22. USA Women's Health Market
23. South America Women's Health Market
24. Brazil Women's Health Market
25. Middle East Women's Health Market
26. Africa Women's Health Market
27. Women's Health Market Competitive Landscape and Company Profiles
28. Key Mergers and Acquisitions in the Women's Health Market
29. Women's Health Market Future Outlook and Potential Analysis
30. Appendix
A selection of companies mentioned in this report includes:
- AbbVie Inc.
- Agile Therapeutics
- Allergan PLC
- Amgen Inc.
- Apothecus Pharmaceutical Corporation
- AstraZeneca PLC
- Bayer AG
- Blairex Laboratories Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Ferring Pharmaceuticals
- Hologic Inc.
- Johnson & Johnson Services Inc.
- Lupin Pharmaceuticals Inc.
- Merck & Co Inc.
- Novartis AG
- Pfizer Inc.
- Siemens AG
- Teva Pharmaceutical Industries Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/jn0wfd
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
